Auffarth Gerd 4
4 · Outlook Therapeutics, Inc. · Filed Apr 21, 2020
Insider Transaction Report
Form 4
Auffarth Gerd
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-04-20+25,000→ 25,000 totalExercise: $0.72Exp: 2030-04-20→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option will vest in three equal annual installments such that the stock option will be fully vested as of the third anniversary of the grant date, subject to (x) the Reporting Person's Continuous Service to the Issuer through such vesting date and (y) acceleration upon a Change in Control.